iRadimed
IRMD
51 hedge funds and large institutions have $44M invested in iRadimed in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 2 closing their positions.
750% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 2
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
59% more capital invested
Capital invested by funds: $27.7M → $44M (+$16.3M)
42% more funds holding
Funds holding: 36 → 51 (+15)
1.91% more ownership
Funds ownership: 18% → 19.91% (+1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.29M |
| 2 |
Renaissance Technologies
New York
|
+$1.13M |
| 3 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$758K |
| 4 |
TCM
Timpani Capital Management
Milwaukee,
Wisconsin
|
+$628K |
| 5 |
State Street
Boston,
Massachusetts
|
+$577K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.21M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$805K |
| 3 |
EP
Eversept Partners
New York
|
-$591K |
| 4 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
-$528K |
| 5 |
UA
Unison Advisors
Washington,
District of Columbia
|
-$413K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PIA
51
Piedmont Investment Advisors
Durham,
North Carolina
| $1K | +$1.08K | +61 | New |
|
|
52
Adage Capital Partners
Boston,
Massachusetts
| – | -$805K | -55,900 | Closed |
|
|
UA
53
Unison Advisors
Washington,
District of Columbia
| – | -$413K | -29,250 | Closed |
|
IRMD Hedge Fund Activity: Q2 2018 in Review
51 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2018, worth a combined $44M — up 59% from $27.7M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new IRMD positions and 2 closed out — a net gain of 15 holders — while 20 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock, adding an estimated $3.29M. The largest seller was Ameriprise, cutting an estimated $3.21M.
- 51 institutional investors held iRadimed (IRMD) as of Q2 2018, up from 36 in Q1 2018.
- Funds reported $44M of iRadimed stock for Q2 2018, up 59% quarter-over-quarter.
- 17 funds opened new iRadimed positions in Q2 2018 and 2 closed out, a net change of +15 holders.
- The largest iRadimed buyer in Q2 2018 was BlackRock, an estimated $3.29M added.
- The largest iRadimed seller in Q2 2018 was Ameriprise, an estimated $3.21M sold.
Based on aggregated 13F filings for Q2 2018.